Filing Details

Accession Number:
0001127602-20-023610
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-14 16:40:56
Reporting Period:
2020-08-12
Accepted Time:
2020-08-14 16:40:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA Biological Products, (No Disgnostic Substances) (2836) 813467528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760669 Stephen Hoge C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-12 932 $69.05 1,965,598 No 4 S Direct
Common Stock Disposition 2020-08-12 3,138 $69.92 1,962,460 No 4 S Direct
Common Stock Disposition 2020-08-12 400 $70.77 1,962,060 No 4 S Direct
Common Stock Disposition 2020-08-12 230 $72.01 1,961,830 No 4 S Direct
Common Stock Disposition 2020-08-12 200 $73.18 1,961,630 No 4 S Direct
Common Stock Disposition 2020-08-12 100 $74.06 1,961,530 No 4 S Direct
Common Stock Acquisiton 2020-08-13 10,000 $0.99 1,971,530 No 4 M Direct
Common Stock Disposition 2020-08-13 10,000 $69.05 1,961,530 No 4 S Direct
Common Stock Disposition 2020-08-13 4,300 $67.80 1,957,230 No 4 S Direct
Common Stock Disposition 2020-08-13 700 $68.49 1,956,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-13 10,000 $0.00 10,000 $0.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
847,431 2023-08-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,116 Indirect By Valhalla, LLC
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.55 to $69.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.56 to $70.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.57 to $71.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.64 to $72.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.90 to $73.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.29 to $68.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.33 to $68.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  9. This option is fully vested and exercisable.